To try to eradicate cancer in a patient, he is infused with mouse monoclonal antibodies to an antigen expressed on his cancer. What is the most probable risk of this treatment?
A) A type I hypersensitivity when the mouse antibodies bind to mast cells.
B) A type II hypersensitivity when the mouse antibodies cross- react with human antigens.
C) A type III hypersensitivity if the patient develops anti- mouse antibodies.
D) A type IV hypersensitivity if the antibodies activate cytotoxic T cells.
Correct Answer:
Verified
Q10: Each hypersensitivity below is paired correctly with
Q11: Which of the type II hypersensitivities listed
Q12: At the end of a prolonged course
Q13: Which of the following is (are)a contraindication(s)for
Q14: Each of the following mediates cell damage
Q16: All of the following are typically associated
Q17: Type IV hypersensitivities have been associated with
A)granulomas.
B)hives.
C)kidney
Q18: Type I hypersensitivities typically occur within
A)2-3 days.
B)5
Q19: Complement is an important component of the
Q20: All of the following hypersensitivities are mediated
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents